Efficacy of aminophylline for treatment of recurrent symptomatic bradycardia after spinal cord injury

Pharmacotherapy

Volumn 28, Issue 1, 2008, Pages 131-135

  Whitman, Craig B ^a   Schroeder, Walter S ^a,c   Ploch, Peter J ^b   Raghavendran, Krishnan ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c NONE   (United States)

Author keywords

Aminophylline; Bradycardia; Spinal cord injury; Tetraplegia

Indexed keywords

ADRENALIN; AMINOPHYLLINE; ATROPINE; CATECHOLAMINE; DOBUTAMINE; EPHEDRINE; ISOPRENALINE; METHYLXANTHINE; TERBUTALINE; THEOPHYLLINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BRADYCARDIA; CASE REPORT; DRUG DOSE REGIMEN; FEMALE; HEART ARRHYTHMIA; HUMAN; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; SPINAL CORD INJURY; SYMPATHETIC INNERVATION; SYMPTOMATOLOGY;

ACUTE DISEASE; ADULT; AMINOPHYLLINE; BRADYCARDIA; CARDIOTONIC AGENTS; FEMALE; HUMANS; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 38049027869     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.1.131     Document Type: Article

References (37)

1. Segal JL, Pathak MS. Optimal drug therapy and therapeutic drug monitoring after spinal cord injury: a population-specific approach. Am J Ther 2001;8(6):451-63.
2. Bunten DC, Warner AL, Brunnemann SR, Segal JL. Heart rate variability is altered following spinal cord injury. Clin Auton Res 1998;8(6):329-34.
3. Lehmann KG, Lane JG, Piepmeier JM, Batsford WP. Cardiovascular abnormalities accompanying acute spinal cord injury in humans: incidence, time course and severity. J Am Coll Cardiol 1987;10(1):46-52.
4. Gilgoff IS, Ward SL, Hohn AR. Cardiac pacemaker in high spinal cord injury. Arch Phys Med Rehab 1991;72(8):601-3.
5. Piepmeier JM, Lehmann KB, Lane JG. Cardiovascular instability following acute cervical spinal cord trauma. Cent Nerv Syst Trauma 1985;2(3):153-60.
6. Ruiz-Arango AF, Robinson VJB, Sharma GK. Characteristics of patients with cervical spinal injury requiring permanent pacemaker implantation. Cardiol Rev 2006;14(4):e8-11.
7. Franga DL, Hawkins ML, Medeiros RS, Adewumi D. Recurrent asystole resulting from high cervical spinal cord injuries. Am Surg 2006;72(6):525-9.
8. Abd AG, Braun NM. Management of life-threatening bradycardia in spinal cord injury. Chest 1989;95(3):701-2.
9. Winslow EB, Lesch M, Talano JV, Meyer PR Jr. Spinal cord injuries associated with cardiopulmonary complications. Spine 1986;11(8):809-12.
10. Eldridge FL, Millhorn DE, Waldrop TG, Kiley JP. Mechanism of respiratory effects of methylxanthines. Respir Physiol 1983;53(2):239-61.
11. Goshgarian HG, Ellenberger HH, Feldman JL. Decussation of bulbospinal respiratory axons at the level of the phrenic nuclei in adult rats: a possible substrate for the crossed phrenic phenomenon. Exp Neurol 1991;111(1):135-9.
12. Murciano D, Aubier M, Lecocguic Y, Pariente R. Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. N Engl J Med 1984;311(6):349-53.
13. Nantwi KD, Goshgarian HG. Actions of specific adenosine receptor A1 and A2 agonists and antagonists in recovery of phrenic motor output following upper cervical spinal cord injury in adult rats. Clin Exp Pharmacol Physiol 2002;29(10):915-23.
14. Sherman MS, Lang DM, Matityahu A, Campbell D. Theophylline improves measurements of respiratory muscle efficiency. Chest 1996;110(6):1437-42.
15. Bascom AT, Lattin CD, Aboussouan LS, Goshgarian HG. Effect of acute aminophylline administration on diaphragm function in high cervical tetraplegia: a case report. Chest 2005;127(2):658-61.
16. Redekop GJ, Del Maestro RF. Vertebral hemangioma causing spinal cord compression during pregnancy. Surg Neurol 1992;38(3):210-15.
17. Schulz-Stubner S. The use of small-dose theophylline for the treatment of bradycardia in patients with spinal cord injury. Anesth Analg 2005;101(6):1809-11.
18. Pasnoori VR, Leesar MA. Use of aminophylline in the treatment of severe symptomatic bradycardia resistant to atropine. Cardiol Rev 2004;12(2):65-8.
19. Sakamoto T, Sadanaga T, Okazaki T. Sequential use of aminophylline and theophylline for the treatment of atropine-resistant bradycardia after spinal cord injury: a case report. J Cardiol 2007;49(2):91-6.
20. Weant KA, Kilpatrick M, Jaikumar S. Aminophylline for the treatment of symptomatic bradycardia and asystole secondary to cervical spine injury. Neurocrit Care 2007, in press.
21. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis 1989;32(1):73-97.
22. Vassallo R, Lipsky JJ. Theophylline: recent advances in the understanding of its mode of action and uses in clinical practice. Mayo Clin Proc 1998;73(4):346-54.
23. Favale S, Di Biase M, Rizzo U, Belardinelli L, Rizzon P. Effect of adenosine and adenosine-5′-triphosphate on atrioventricular conduction in patients. J Am Coll Cardiol 1985;5(5):1212-19.
24. Abu-Laban RB, McIntyre CM, Christenson JM, et al. Aminophylline in bradyasystolic cardiac arrest: a randomised placebo-controlled trial. Lancet 2006;367(9522):1577-84.
25. Alboni P, Rossi P, Ratto B, Pedroni P, Gatto E, Antonioli GE. Electrophysiologic effects of oral theophylline in sinus bradycardia. Am J Cardiol 1990;65(15):1037-9.
26. Bertolet BD, Eagle DA, Conti JB, Mills RM, Belardinelli L. Bradycardia after heart transplantation: reversal with theophylline. J Am Coll Cardiol 1996;28(2):396-9.
27. Cawley MJ, Al-Jazairi AS, Stone EA. Intravenous theophylline: alternative to temporary pacing in the management of bradycardia secondary to AV nodal block. Ann Pharmacother 2001;35(3):303-7.
28. Kragie L, Sekovski B. Theophylline - an alternative therapy for bradyarrhythmia in the elderly. Pharmacotherapy 1992;12(4): 324-30.
29. Ling CA, Crouch MA. Theophylline for chronic symptomatic bradycardia in the elderly. Ann Pharmacother 1998;32(7-8): 837-9.
30. Nelson SD, Stanley M, Love CJ, Coyne KS, Schaal SF. The autonomic and hemodynamic effects of oral theophylline in patients with vasodepressor syncope. Arch Intern Med 1991;151(12):2425-9.
31. Vestal RE, Eiriksson CE Jr, Musser B, Ozaki LK, Halter JB. Effect of intravenous aminophylline on plasma levels of catecholamines and related cardiovascular and metabolic responses in man. Circulation 1983;67(1):162-71.
32. 2+. Proc Natl Acad Sci U S A 1972;69(4):834-6.
33. Poisner AM. Direct stimulant effect of aminophylline on catecholamine release from the adrenal medulla. Biochem Pharmacol 1973;22(4):469-76.
34. Segal JL, Gordon SK, Eltorai IM. Theophylline disposition in tetraplegic man. S Med J 1987;80(6):720-4.
35. Segal JL, Smith CM, Gordon SK, Eltorai IM. Theophylline pharmacokinetics in paraplegic subjects. Clin Pharm 1985;4(4):448-51.
36. Segal JL, Brunnemann SR, Gordon SK, Eltorai IM. The absolute bioavailability of oral theophylline in patients with spinal cord injury. Pharmacotherapy 1986;6(1):26-9.
37. Segal JL, Brunnemann SR. Clinical pharmacokinetics in patients with spinal cord injuries. Clin Pharmacokinet 1989;17(2):109-29.